This HTML5 document contains 36 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
n11http://linked.opendata.cz/resource/drugbank/drug/DB08982/identifier/drugbank/
dctermshttp://purl.org/dc/terms/
n6http://bio2rdf.org/drugbank:
n10http://linked.opendata.cz/resource/drugbank/drug/DB08982/identifier/chebi/
admshttp://www.w3.org/ns/adms#
n9http://linked.opendata.cz/resource/drugbank/drug/DB08982/identifier/wikipedia/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n3http://linked.opendata.cz/ontology/drugbank/
n4http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#

Statements

Subject Item
n2:DB08982
rdf:type
n3:Drug
n3:description
Etozoline (Diulozin, Elkapin, Etopinil) is a loop diuretic used in Europe.
n3:group
approved
owl:sameAs
n6:DB08982
dcterms:title
Etozoline
adms:identifier
n9:Etozoline n10:553487 n11:DB08982
n3:synthesisReference
U.S. Patent 3,072,653.
n3:IUPAC-Name
n4:271B61D9-363D-11E5-9242-09173F13E4C5
n3:InChI
n4:271B61DF-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n4:271B61DE-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n4:271B61DB-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n4:271B61DC-363D-11E5-9242-09173F13E4C5
n3:SMILES
n4:271B61DD-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n4:271B61D7-363D-11E5-9242-09173F13E4C5
n3:logP
n4:271B61D5-363D-11E5-9242-09173F13E4C5 n4:271B61D8-363D-11E5-9242-09173F13E4C5
n3:logS
n4:271B61D6-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n4:271B61E5-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n4:271B61E6-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n4:271B61E0-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n4:271B61E1-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n4:271B61E3-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n4:271B61E2-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n4:271B61E4-363D-11E5-9242-09173F13E4C5
n3:casRegistryNumber
73-09-6
n3:Bioavailability
n4:271B61EA-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n4:271B61EC-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n4:271B61ED-363D-11E5-9242-09173F13E4C5
n3:Melting-Point
n4:271B61EE-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n4:271B61E9-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n4:271B61E8-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n4:271B61EB-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n4:271B61DA-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n4:271B61E7-363D-11E5-9242-09173F13E4C5